Prentice Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Prentice Wealth Management's PFE Position: Q3 2025 in Review
Prentice Wealth Management sold out of Pfizer (PFE) in Q3 2025, closing a stake of 11,451 shares — an estimated $278K sold.
Prentice Wealth Management first reported a position in PFE in Q1 2021 and held it in 17 quarters. The position peaked at $469K in Q4 2024. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.
- Prentice Wealth Management reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
- Prentice Wealth Management sold 11,451 Pfizer shares in Q3 2025, an estimated $278K.
- Prentice Wealth Management first reported a position in Pfizer in Q1 2021 and held it in 17 quarters.
- Prentice Wealth Management's Pfizer position peaked at $469K in Q4 2024.
- 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.
Based on Prentice Wealth Management's 13F filing for Q3 2025, filed 9 Oct 2025.